Arteris, Inc. (NASDAQ:AIP) Short Interest Up 15.6% in December

Arteris, Inc. (NASDAQ:AIP) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 356,200 shares, a growth of 15.6% from the December 15th total of 308,100 shares. Currently, 1.4% of the company’s stock are short sold. Based on an average daily volume of 204,000 shares, the short-interest ratio is presently 1.7 days.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reissued a “buy” rating and issued a $15.00 target price on shares of Arteris in a research report on Wednesday, November 6th.

Insider Buying and Selling at Arteris

In other Arteris news, Director Saiyed Atiq Raza sold 2,776 shares of Arteris stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $12.34, for a total transaction of $34,255.84. Following the completion of the sale, the director now directly owns 684,320 shares of the company’s stock, valued at $8,444,508.80. The trade was a 0.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Wayne C. Cantwell sold 5,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $11.01, for a total value of $55,050.00. Following the transaction, the director now directly owns 233,198 shares of the company’s stock, valued at approximately $2,567,509.98. This represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 325,456 shares of company stock valued at $3,355,352 in the last quarter. Corporate insiders own 33.70% of the company’s stock.

Institutional Trading of Arteris

A number of institutional investors have recently bought and sold shares of the company. US Bancorp DE purchased a new stake in shares of Arteris in the third quarter valued at about $34,000. The Manufacturers Life Insurance Company acquired a new position in shares of Arteris during the 2nd quarter worth approximately $86,000. Algert Global LLC purchased a new stake in Arteris in the 2nd quarter valued at approximately $115,000. MetLife Investment Management LLC grew its holdings in Arteris by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after buying an additional 9,551 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new position in Arteris during the fourth quarter worth $134,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Arteris Stock Performance

Shares of NASDAQ AIP traded up $0.03 during trading on Friday, hitting $11.48. 174,740 shares of the company were exchanged, compared to its average volume of 326,439. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. Arteris has a 1 year low of $4.91 and a 1 year high of $12.64. The firm’s fifty day moving average price is $9.68 and its 200 day moving average price is $8.33.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.